Will Enfusion (ENFN) Grow Revenue And Expand Margins In The Future?
Next Century Growth Investors, LLC, an investment Management Company, released its “Micro-Cap Strategy” fourth-quarter investor letter. A copy of the letter can be downloaded here.
Enfusion Inc. (ENFN)
Market is closed
Sector: Services-Prepackaged Software
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 12 West Capital Management Joel Ramin | 1,903,190 | $17,604,508 | 1.58% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.00 | 722,707 | Director | 722,707 | 2021-10-25 | Filing | |
| $17.00 | 538,887 | Director | 538,887 | 2021-10-25 | Filing | |
| $17.00 | 722,707 | Large Shareholder | 722,707 | 2021-10-25 | Filing | |
| $17.00 | 538,887 | Large Shareholder | 538,887 | 2021-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.73 | 108 | Officer | 30,840 | 2024-02-29 | Filing | |
| $8.73 | 27 | Officer | 17,570 | 2024-02-29 | Filing | |
| $8.65 | 1,770 | Director | 34,471 | 2024-01-10 | Filing | |
| $8.95 | 1,355 | Large Shareholder, Officer, Director | 269,954 | 2024-01-09 | Filing | |
| $9.23 | 1,295 | Large Shareholder, Officer, Director | 271,309 | 2024-01-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,817,661 | $114,631,312 | 1.71% | |
| 2. | 5,030,000 | $48,791,000 | 0.92% | |
| 3. | 3,601,519 | $34,934,733 | 0% | |
| 4. | 2,510,927 | $24,355,992 | 0% | |
| 5. | 1,635,761 | $15,866,859 | 0% |
News See All
Enfusion, Inc. (NYSE:ENFN) Q4 2023 Earnings Call Transcript
Enfusion, Inc. misses on earnings expectations. Reported EPS is $0.04 EPS, expectations were $0.06. Enfusion, Inc.
Enfusion, Inc. (NYSE:ENFN) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Enfusion's Third Quarter 2023 Earnings Conference Call.
Enfusion, Inc. (NYSE:ENFN) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Enfusion Second Quarter 2023 Earnings Conference Call.
Hedge Fund and Insider Trading News: Ken Griffin, Crispin Odey, Ray Dalio, Irenic Capital Management, Elliott Management, BFAM Partners, Comtech Telecomm. Corp. (CMTL), Zymeworks Inc. (ZYME), and More
A group of partners at Odey Asset Management has announced the removal of Crispin Odey, the prominent City tycoon and donor to the Conservative Party, from the hedge fund he established, in response to...
Enfusion, Inc. (NYSE:ENFN) Q1 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion's First Quarter 2023 Earnings Conference Call. As a reminder, this conference call is being recorded.
Should You Consider Investing for the Long-Term in Enfusion Inc. (ENFN)?
Baron Funds, an asset management firm, published its “Baron Discovery Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Billionaire Hedge Funds
